NASDAQ: MBRX
Moleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?

Insider buying vs selling

Have Moleculin Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Walter V. KlempCEO and President2025-06-23675,675$0.37
$250.00kBuy
Jonathan P. FosterChief Financial Officer2025-06-23270,270$0.37
$100.00kBuy
Walter V. KlempCEO and President2025-06-222,190$0.27
$584.73Sell
Jonathan P. FosterChief Financial Officer2025-06-221,054$0.27
$281.42Sell
Donald H. PickerChief Science Officer2025-06-22430$0.27
$114.81Sell
Walter V. KlempCEO and President2025-06-20914$0.27
$244.04Sell
Jonathan P. FosterChief Financial Officer2025-06-20661$0.27
$176.49Sell
Donald H. PickerChief Science Officer2025-06-20263$0.27
$70.22Sell
Walter V. KlempCEO and President2025-06-16406$0.69
$278.11Sell
Jonathan P. FosterChief Financial Officer2025-06-16203$0.69
$139.06Sell

1 of 1

MBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MBRX insiders and whales buy or sell their stock.

MBRX Shareholders

What type of owners hold Moleculin Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Waldemar Priebe12.04%3,645,573$1.36MInsider
Walter V. Klemp6.00%1,818,607$680.16kInsider
Donald H. Picker1.86%562,152$210.24kInsider
Jonathan P. Foster0.95%287,587$107.56kInsider
Citigroup Inc0.28%85,283$31.90kInstitution
Xtx Topco Ltd0.25%74,217$27.76kInstitution
Virtu Financial LLC0.20%59,278$22.17kInstitution
Lpl Financial LLC0.19%56,080$20.97kInstitution
Verus Capital Partners LLC0.14%43,000$16.08kInstitution
Vanguard Group Inc0.10%30,935$11.57kInstitution

1 of 3

MBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MBRX1.43%20.90%Net BuyingNet Buying
SNGX0.18%99.82%
PHIO0.16%99.84%Net BuyingNet Selling
MRKR2.40%97.60%Net Buying
THAR1.80%98.20%Net BuyingNet Buying

Moleculin Biotech Stock Ownership FAQ

Who owns Moleculin Biotech?

Moleculin Biotech (NASDAQ: MBRX) is owned by 1.43% institutional shareholders, 20.90% Moleculin Biotech insiders, and 77.67% retail investors. Waldemar Priebe is the largest individual Moleculin Biotech shareholder, owning 3.65M shares representing 12.04% of the company. Waldemar Priebe's Moleculin Biotech shares are currently valued at $1.44M.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.